Okita, A.L. et al. 2020. Secukinumab: Rapid Efficacy in Psoriasis After Primary Failure With Ustekinumab and Adalimumab. Dermatology Practical & Conceptual. 10, 4 (Oct. 2020), e2020102. DOI:https://doi.org/10.5826/dpc.1004a102.